Voyager Acquisition Corp announced the pricing of its $220 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VACHU”, Thursday, August 9, 2024.

The new SPAC intends to search for a healthcare target with strong competitive positioning and a scalable growth platform sourced through its proprietary channels.

Voyager’s sponsor team is to be led by President, CEO and Director Adeel Rouf alongside CFO Alex Rogers, VP of M&A Warren Hosseinion Jr. and Chairman Warren Hosseinion. Oded Levy and Jonathan Intrater are join Hosseinion Sr. on its Board of Directors.

Total SPAC deal count for 2024 year-to-date is now 24. This offering is expected to close on Monday, August 12, 2024.

Cantor Fitzgerald is acting as sole book-running manager with Odeon Capital Group acting as co-manager for the offering. Winston & Strawn LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. Withum Smith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.